Communication from the ISTH SSC Subcommittee on Hemostasis and Malignancy: A meta-analysis to assess the risk of bleeding and thrombosis following CAR T-cell therapy

CONCLUSION: The risk of both thrombosis and bleeding following CAR T-cell therapy appears to be highest in the initial months following infusion.PMID:38574863 | DOI:10.1016/j.jtha.2024.03.021

Source: Thrombosis and Haemostasis - April 4, 2024 Category: Hematology Authors: Poorva Bindal Rushad Patell Thita Chiasakul Mandy N Lauw Amica Ko Tzu-Fei Wang Jeffrey I Zwicker Source Type: research